Lumbrokinase, a potent fibrinolytic enzyme, originates from the earthworm Lumbricus rubellus. Its discovery and subsequent research have unveiled its significant potential in cardiovascular health, primarily through its ability to break down fibrin, a key protein in blood clot formation. The scientific exploration of Lumbrokinase involves understanding its biochemical properties and therapeutic effects. Key Discoveries and Applications: * Fibrin Degradation: Research has confirmed Lumbrokinase's capacity to directly degrade fibrin and fibrinogen, thereby aiding in the dissolution of blood clots. This makes it a subject of interest for conditions related to thrombosis. * Clinical Studies: Clinical trials, particularly in Asia, have investigated Lumbrokinase's efficacy in improving blood circulation, reducing blood viscosity, and potentially alleviating symptoms associated with cardiovascular issues like angina and stroke after-effects. * Safety Profile: Studies indicate a favorable safety profile for Lumbrokinase, with minimal reported side effects, making it a potentially safer alternative for certain applications compared to conventional treatments. However, as with any supplement, medical advice should be sought before use. * Research Focus: Ongoing research continues to explore the full potential of Lumbrokinase, including its role in managing conditions linked to blood clot formation and inflammation, such as Long COVID. As research progresses, Lumbrokinase emerges as a promising natural compound with significant therapeutic potential. Its unique properties offer exciting possibilities for improving cardiovascular health and managing conditions related to blood circulation.